“The Revised Global Consensus Statement on
Menopausal Hormone Therapy is aimed at
updating and expanding the areas of consensus”.1
Umbrella
What may the Hormone Therapy 2016 Revised Global Consensus Statement Umbrella include?
Depending on the Source (DotS) this Umbrella may include:
- Hormone Replacement Therapy (HRT)
- Hormone Therapy (HT)
- Menopausal Hormone Therapy (MHT)
- Revised Global Consensus Statement on Menopausal Hormone Therapy
Revised Global Consensus Statement
What is the Revised Global Consensus Statement on Menopausal Hormone Therapy?
In the Revised Global Consensus Statement on Menopausal Hormone Therapy (Revised Global Consensus Statement) – endorsed by seven menopause-related organizations – published online 20 June 2016, the authors explain:
Organizations
Which organizations endorse the Revised Global Consensus Statement?
Organizations which endorse the Revised Global Consensus Statement (in alphabetical order) are the:
- Asia Pacific Menopause Federation
- Endocrine Society
- European Menopause and Andropause Society
- Federation of Latin American Menopause Societies
- International Menopause Society
- International Osteoporosis Foundation
- North American Menopause Society
Informed Decision
What are the Revised Global Consensus Statement authors hopeful of?
The Revised Global Consensus Statement authors note:
“Hopefully, this statement will enable health-care providers to offer those women in midlife, who may benefit from MHT, the opportunity to make an informed decision”.3
Acknowledgement
What do the Revised Global Consensus Statement authors acknowledge?
The Revised Global Consensus Statement authors acknowledge:
Consensus
What are some points of consensus in the Revised Global Consensus Statement?
Some points of consensus are:

- “MHT, including tibolone and the combination of conjugated equine estrogens and bazedoxifene (CE/BZA), is the most effective treatment for vasomotor symptoms (VMS) associated with menopause at any age, but benefits are more likely to outweigh risks if initiated for symptomatic women before the age of 60 years or within 10 years after menopause
- If MHT is contraindicated or not desired for treatment of VMS, selective serotonin reuptake inhibitors and serotoninnorepinephrine reuptake inhibitors such as paroxetine, escitalopram, venlafaxine and desvenlafaxine, which have been shown to be effective in randomized controlled trials (RCTs), may be considered. Gabapentin may also be considered
- Local low-dose estrogen therapy is preferred for women whose symptoms are limited to vaginal dryness or associated discomfort with intercourse or for the prevention of recurrent urinary tract infections”.5
Vasomotor Symptoms
What are vasomotor symptoms?
DotS the definition of vasomotor symptoms may vary. The North American Menopause Society’s definition is:
Health Care Provider
What if I choose to use MHT?
If you choose to use MHT, it may be in your best interest to also choose to talk to your health care provider about this.
One of the points of consensus in the Revised Global Consensus Statement is:
- “The option of MHT is an individual decision in terms of quality of life and health priorities as well as personal risk factors such as age, time since menopause and the risk of VTE, stroke, ischemic heart disease and breast cancer. MHT should not be recommended without a clear indication for its use”.7
What is VTE?
MHT can be an abbreviation for Venous Thromboembolism.
Health Topics A-Z
Where may I find Health Topics related to Hormone Therapy 2016 Revised Global Consensus Statement?
In Health Topics A-Z you may find:
Links
Where may I find Links related to Hormone Therapy 2016 Revised Global Consensus Statement?
Your Country may have Links similar to:
Links
This Links List to third party websites is neither comprehensive nor exhaustive. Inclusion on this Links List does not imply endorsement or recommendation. Non-inclusion on this Links List does not imply non-endorsement or non-recommendation. Third party websites are not under the control of Meno Martha International Menopause Directory. Third party websites may contain explicit medical images and/or sexual references. Please read Meno Martha International Menopause Directory’s Links Policy before proceeding to a Link. Please contact Webmaster if you experience a problem with a Link.New or Updated
- 2016 IMS Recommendations on Women’s Midlife Health and Menopause Hormone Therapy
- 9 Myths and Misunderstandings About Menopausal Hormone Therapy (MHT)
- Askearlymenopause.org [Ask EM] [+ Video: What Is Early Menopause?]
- BMS & WHC’s 2020 Recommendations on Hormone Replacement Therapy In Menopausal Women
- Bioidentical Custom Compounded Hormone Therapy
- Bioidentical Hormone Therapy
- Bioidentical Hormones Explained – A British Menopause Society Video
- Bioidentical Hormones: Are They Safer?
- Combined Menopausal Hormone Therapy (MHT)
- Complementary Medicine Options for Menopausal Symptoms
- Complementary and Alternative Therapies Explained – A British Menopause Society Video
- Compounded Bioidentical Hormone Therapy [Video]
- Compounded Bioidentical Hormones In Endocrinology Practice: An Endocrine Society Scientific Statement
- Deciding About Hormone Therapy
- Deciding About Hormone Therapy Use
- Dr Gail Busby – I Forgot To Ask the Doctor – Episode 9 The Menopause
- EMAS Menopause Essentials
- EMAS Replay [Multiply Languages]
- Early Menopause: Experiences and Perspectives of Women and Health Practitioners – Women’s Profiles
- Estrogen & Hormones: Estrogen & Heart Disease
- Find A Menopause Practitioner [United States and Other]
- Find An AMS Doctor [Australasian Menopause Society i.e. Australia and New Zealand]
- Find Your Nearest BMS Menopause Specialist [British Menopause Society]
- Global Consensus Statement on Menopausal Hormone Therapy
- HRT & Menopause Extra
- HRT and Bleeding Explained – A British Menopause Society Video
- HRT and Breast Cancer: Overall Risks and Benefits Explained – A British Menopause Society Video
- HRT and the Risk of Breast Cancer Explained – A British Menopause Society Video
- HRT – Types, Doses and Regimens
- HRT: Benefits and Risks
- HRT: The History
- Hormone Replacement Therapy
- Hormone Replacement Therapy (HRT)
- Hormone Replacement Therapy (HRT) Explained – A British Menopause Society Video
- Hormone Replacement Therapy (HRT): Risks of HRT
- Hormone Replacement Therapy (HRT): Types
- Hormone Therapy In Postmenopausal Persons: Primary Prevention of Chronic Conditions
- Hormone Therapy: Is It Right for You?
- Hot Flashes
- Hot Flashes: What Can I Do? [+ Video: What Are the Signs and Symptoms of Menopause?]
- Jean Hailes MHT Position Statement
- Joint Position Statement by the British Menopause Society, Royal College of Obstetricians and Gynaecologists and Society for Endocrinology on Best Practice Recommendations for the Care of Women Experiencing the Menopause
- Later Years (Around 50 Years and Over): Menopause and Post Menopause Health – Hormone Replacement Therapy (HRT) [+ Video: Is HRT Bad for You?]
- Let’s Talk About Perimenopause
- MHT Still Maligned & Misunderstood: Expert
- MHT and Breast Cancer Risk
- Making Choices At Menopause
- Making Sense of Menopausal Hormone Therapy Means Understanding the Benefits As Well As the Risks
- Managing Your Symptoms
- Mayo Clinic Q and A: Estrogen Replacement Therapy After Ovary Removal
- Menopausal Hormone Therapy
- Menopausal Hormone Therapy Trends Before Versus After 2002: Impact of the Women’s Health Initiative Study Results
- Menopausal Hormone Therapy and Breast Cancer Risk
- Menopausal Hormone Therapy and Venous Thromboembolism
- Menopausal Hormone Therapy and Women’s Health: An Umbrella Review
- Menopausal Hormone Therapy – Fact Sheet
- Menopausal Hormone Therapy, Heart Disease and Stroke
- Menopause
- Menopause
- Menopause
- Menopause
- Menopause & Hormones: Questions To Ask Your Doctor
- Menopause Hormone Therapy: Who Shouldn’t Take It?
- Menopause Management Options
- Menopause Map: Downloadable Resources – My Personal Path Print Tools: Menopause Medication Tracker
- Menopause Map: Downloadable Resources – My Personal Path Print Tools: Questions for Your Health Care Provider
- Menopause Patient Information [Videos] 3. The Risks & Benefits of HRT
- Menopause Patient Information [Videos] 4. The Different Types of HRT
- Menopause Preparedness Toolkit Video Series: Treating Vasomotor Symptoms of Menopause
- Menopause Symptoms and Relief
- Menopause Symptoms: Mayo Clinic Expert Outlines Hormone and Nonhormonal Therapies
- Menopause Treatment
- Menopause Treatment
- Menopause Treatments: What Works, What Doesn’t
- Menopause: Diagnosis and Management – Information for the Public: Questions To Ask About Menopause [NICE Guideline]
- Menopause: Menopause – Hormone Treatments
- NAMS Supports Judicious Use of Systemic Hormone Therapy for Women Aged 65 Years and Older
- National Center for Complementary and Integrative Health: Know the Science: How Medications and Supplements Can Interact
- National Center for Complementary and Integrative Health: Menopausal Symptoms In Depth
- Navigating Menopause: Expert Insights and Solutions | Dr Susan Davis | The Proof Podcast EP 245
- Oestrogen Only Menopausal Hormone Therapy
- Revised Global Consensus Statement on Menopausal Hormone Therapy
- Risks and Benefits of MHT
- The North American Menopause Society Releases Its 2022 Hormone Therapy Position Statement
- Tips To Help Manage Menopause Symptoms
- Types of Hormone Therapy
- Urogenital Atrophy Explained – A British Menopause Society Video
- Using HRT (Hormone Replacement Therapy)
- Vaginal Dryness
- Vaginal Dryness
- Video Series-2021: Treatment Options for Vaginal Dryness and Urinary Issues
- Video Series-2021: What Women Need to Know About Hormone Therapies
- Video Series-2022: Hormone Therapy: Understanding the Risks and Benefits
- Video Series-2022: Perimenopause, Signs, Symptoms, and Solutions
- Webinars: Previous – 2021 Vision: Practical Steps to Optimize Your Benefit-Risk. Discussions for A New Decade
- Webinars: Previous – Breast Cancer
- Webinars: Previous – Primary Prevention of Cardiovascular Disease With MHT – Where Are We Now?
- Webinars: Previous – The Early Menopausal Patient
- What Are the Benefits and Risks of HRT?
- What Everyone Should Know About Menopause Symptoms
Sources
Where may I find the Sources quoted?
You may find the Sources quoted at:
Sources
- De Villiers, T. J., Hall, J. E., Pinkerton, J. V., Pérez, S. C., Rees, M., Yang, C. and Pierroz, D. D. Revised Global Consensus Statement on Menopausal Hormone Therapy: Introduction. Climacteric, 2016;19:4:313 https://www.imsociety.org/wp-content/uploads/2020/08/global-consensus-hrt-2016-06.pdf Accessed: 11 February 2023
- De Villiers, T. J., Hall, J. E., Pinkerton, J. V., Pérez, S. C., Rees, M., Yang, C. and Pierroz, D. D. Revised Global Consensus Statement on Menopausal Hormone Therapy: Introduction. Climacteric, 2016;19:4:313 https://www.imsociety.org/wp-content/uploads/2020/08/global-consensus-hrt-2016-06.pdf Accessed: 11 February 2023
- De Villiers, T. J., Hall, J. E., Pinkerton, J. V., Pérez, S. C., Rees, M., Yang, C. and Pierroz, D. D. Revised Global Consensus Statement on Menopausal Hormone Therapy: Introduction. Climacteric, 2016;19:4:313 https://www.imsociety.org/wp-content/uploads/2020/08/global-consensus-hrt-2016-06.pdf Accessed: 11 February 2023
- De Villiers, T. J., Hall, J. E., Pinkerton, J. V., Pérez, S. C., Rees, M., Yang, C. and Pierroz, D. D. Revised Global Consensus Statement on Menopausal Hormone Therapy: Introduction. Climacteric, 2016;19:4:313 https://www.imsociety.org/wp-content/uploads/2020/08/global-consensus-hrt-2016-06.pdf Accessed: 11 February 2023
- De Villiers, T. J., Hall, J. E., Pinkerton, J. V., Pérez, S. C., Rees, M., Yang, C. and Pierroz, D. D. Revised Global Consensus Statement on Menopausal Hormone Therapy: Section A: Benefit/Risk Profile of MHT. Climacteric, 2016;19:4:313 https://www.imsociety.org/wp-content/uploads/2020/08/global-consensus-hrt-2016-06.pdf Accessed: 11 February 2023
- Menopause Glossary: V – Vasomotor Symptoms. North American Menopause Society http://www.menopause.org/for-women/menopause-glossary#V Accessed: 11 February 2023
- De Villiers, T. J., Hall, J. E., Pinkerton, J. V., Pérez, S. C., Rees, M., Yang, C. and Pierroz, D. D. Revised Global Consensus Statement on Menopausal Hormone Therapy: Section B: General Principles Governing the Use of MHT. Climacteric, 2016;19:4:314 https://www.imsociety.org/wp-content/uploads/2020/08/global-consensus-hrt-2016-06.pdf Accessed: 11 February 2023